Search Within

Rajmohan Murali

  1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (4)
  3. Editorial (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  2. Department of Pathology and Laboratory Medicine (17)
  3. GDMT, Pathology and Laboratory Medicine (17)
  4. GSK Faculty (17)
  5. Gynecology Disease Management Team (17)
  6. Human Oncology and Pathogenesis Program (15)

More Groups

People
  1. Michael Berger (8)
  2. Nancy Bouvier (5)
  3. Nicholas Socci (5)
  4. Thomas Wiesner (5)
  5. Agnes Viale (4)
  6. Kety Huberman (4)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (3)
  6. 2018 (3)

More Years

Publications
  1. Clinical Cancer Research (2)
  2. Nature (2)
  3. Blood (1)
  4. Cancer Cell (1)
  5. International Journal of Gynecological Cancer (1)
  6. JCO Clinical Cancer Informatics (1)

More Publications

Publishers
  1. Nature Publishing Group (5)
  2. American Association for Cancer Research (2)
  3. American Association for the Advancement of Science (1)
  4. American Society of Clinical Oncology (1)
  5. American Society of Hematology (1)
  6. Cell Press (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain
    Journal Article

    Gan, S.; Macalinao, D. G.; Shahoei, S. H.; Tian, L.; Jin, X.; Basnet, H.; Bibby, C.; Muller, J. T.; Atri, P.; Seffar, E.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
    Journal Article

    DeWolf, S.; Elhanati, Y.; Nichols, K.; Waters, N. R.; Nguyen, C. L.; Slingerland, J. B.; Rodriguez, N.; Lyudovyk, O.; Giardina, P. A.; Kousa, A. I.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes
    Editorial

    Bolton, K. L.; Chen, D.; de la Fuente, R. C.; Fu, Z.; Murali, R.; KoĢˆbel, M.; Tazi, Y.; Cunningham, J. M.; Chan, I. C. C.; Wiley, B. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • OncoTree: A cancer classification system for precision oncology
    Journal Article

    Kundra, R.; Zhang, H.; Sheridan, R.; Sirintrapun, S. J.; Wang, A.; Ochoa, A.; Wilson, M.; Gross, B.; Sun, Y.; Madupuri, R.; more...
    JCO Clinical Cancer Informatics (2021)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Distant metastatic spread and clonal evolution of high-grade endometrial cancers
    Meeting Abstract

    Miller, K.; Selenica, P.; Reis-Filho, J.; Abu-Rustum, N. R.; Makker, V.; Aghajanian, C. A.; Iacobuzio-Donahue, C. A.; Murali, R.; Weigelt, B.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Positron lymphography via intracervical (18)F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies
    Journal Article

    Mueller, J. J.; Dauer, L. T.; Murali, R.; Iasonos, A.; Pandit-Taskar, N.; Abu-Rustum, N. R.; Grimm, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
    Journal Article

    Hieronymus, H.; Murali, R.; Tin, A.; Yadav, K.; Abida, W.; Moller, H.; Berney, D.; Scher, H.; Carver, B.; Scardino, P.; more...
    eLife (2018)

    Fulltext@MSK | Save
  • HER kinase inhibition in patients with HER2-and HER3-mutant cancers
    Journal Article

    Hyman, D. M.; Piha-Paul, S. A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G. I.; Juric, D.; Quinn, D. I.; Moreno, V.; Doger, B.; more...
    Nature (2018)

    Fulltext@MSK | Save